Key Findings

 

FDA Streamlines Tedious Regulatory Process of Cancer Profiling Test Authorization

 

The U.S. Food and Drug Administration (FDA) regulates the safety, effectiveness, sales and distribution of cancer profiling tests. On November 15, 2017, FDA authorized Memorial Sloan Kettering Cancer Center’s (MSK) IMPACT (Integrated Mutation Profiling of Actionable Cancer Targets) tumor profiling test. The test is capable of high throughput screening and identification of a higher number of mutations using biomarkers of different cancer types.

 

Cancer Profiling Complements Ongoing Precision Oncology R&D Activities

 

Traditionally treated on the basis of body location with a one-size-fits-all approach, cancer treatment is evolved significantly wherein precision medicine has aided in better cancer management. Identification of the target mutation with cancer profiling assists in determining highly specific drug that delivers long-lasting remission and expansion of lifetime.

 

Request Report Brochure@

https://www.factmr.com/connectus/sample?flag=B&rep_id=358

Cancer Profiling Market - Competitive Landscape

 

In the competitive landscape of the cancer profiling market report, competition scenario of the market is explained in terms of a dashboard view of all the key players and their relative presence in the global market. The section has also identified prominent players in cancer profiling market, emerging players, mid-size players and other key players in the cancer testing market.

 

The section of company profiles delivers vital information such as product offerings, products in clinical trials and company developments. Few of the profiles players in the cancer profiling market report include F. Hoffmann La Roche Ltd, Illumina Inc, QIAGEN, Thermo Fisher Scientific Inc, Abbott, Nanostring Technologies Inc,  Siemens AG, HTG Molecular Diagnostics, Inc, Perkin Elmer Inc, Agilent Technologies Inc, Negenomics Laboratory Inc, Genomic Health, Biogenex and Pacific Biosciences of California, Inc.

 

Rising Cancer Burden Necessitates Utilization of Cancer Profiling Tests

 

According to the World Health Organization (WHO), cancer is the second leading cause of death globally and is responsible for nearly 9.6 million deaths in 2018 worldwide. While major strides are being made to prevent cancer development, the medical community still need to address the estimates of new cancer cases projected in coming years. WHO estimates the global burden of cancer to have risen to 18.1 million new cases in 2018.

 

As the incidences of rare cancer continue to rise, personalized medicine is providing promising results in cancer treatment. Cancer profiling is aiding the personalized treatments by providing the identification of specific gene mutation and use of targeted therapies.

 

Visit For TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=358

 

Development of Datasets and Interpretation Tools Increases Cancer Profiling Precision

 

Major R&D investments in the cancer profiling market are being utilized in developing platforms for genomic data and clinical information to enhance the current capabilities of genomic profiling tests for different types of cancers. The current landscape of cancer profiling is facing challenges of clinical translations due to lack of sufficient consensus for treatment development and time-consuming interpretation.

 

With the growing emphasis on collaborative treatment to address cancer treatment issues effectively, development of common datasets is underway which can be used to interpret cancer profiling results and improve the treatment of cancer patients.

 

Cancer Profiling - Definition

 

Cancer profiling is a type of molecular profiling that provides specific information of molecular and genetic makeup of cancer tissues or cells. The information reveals abnormalities or altered levels of gene expression and assists in medical professionals to determine focused treatment of different cancer types.

 

Cancer Profiling Market - About the Report

 

Fact.MR has compiled a study on the cancer profiling and published a new report titled, “Cancer Profiling Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028.” The cancer profiling market report delivers a thorough analysis of the market that derives actionable and valuable insights.

 

Cancer Profiling Market Structure

 

The cancer profiling market is studied thoroughly for different facets such as types of cancer and associated diagnostic testing methods. In addition, regulation and reimbursement scenario is also considered to design the cancer profiling market structure. The cancer profiling market is segmented on the basis of product type, indication, end user and test type. The cancer profiling market is also studied for key regions to derive global forecast.

 

Cancer Profiling Market - Additional Questions Answered

 

In addition to the aforementioned insights, the cancer profiling market report delivers intelligent insights based on a thorough assessment of all the market facets. These insights can answer to some of the bemusing questions of the business professional interested in the cancer profiling market.

 

• Which product type in the cancer profiling market will register significant demand by the end of the assessment period?
• Which region presents considerable utilization of cancer profiling tools?
• Among different test types, which test type will be highly sought after in the cancer profiling market during the forecast period?
• Which end-user will register leading utilization of cancer profiling tests during the forecast period?
• Cancer Profiling Market - Research Methodology

 

Report Analysis@ https://www.factmr.com/report/358/cancer-profiling-market

 

A robust research methodology is used to derive the insights and forecast of the cancer profiling market. Study of the cancer profiling market is based on a systematic approach that follows the methodology of the research.

 

The research entails elaborated interviews with industry savants as well as study of cancer profiling industry data. The former comprised primary research approach whereas the latter included secondary research. In the research methodology section of the cancer profiling market report, sources used to carry out primary and secondary research are also given that enable readers to determine the credibility of the data derived in the cancer profiling market report.

 

About Fact.MR

 

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

 

Contact Us

 

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Web: https://www.factmr.com/  

Follow us in Linkedin: https://www.linkedin.com/company/factmr/